LivingGLP1
Study S002440

Evaluation of the Benefit at 6 Months of a 3 Weeks Spa Treatment in the Type 2 Diabetic Patient. Multicenter Randomized Therapeutic Trial

Registration

Registration
NCT03912623
Acronym
DIABEO2THERMES
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
UNKNOWN
Enrollment
200
Start
2019-09-13
Primary completion
2022-03-01
Lead sponsor
Association Francaise pour la Recherche Thermale
Conditions
Diabetes Mellitus; Physical Activity; Dietetic Rules; Therapeutic Education
Interventions
OTHER:SPA Treatment with therapeutic education and physical activity; OTHER:Week end
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • HbA1c evolution [6 months]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0019453A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes.
Ampudia-Blasco FJ, Diabetes technology & therapeutics
2015OtherPMID 25347226DOIregistry reference BACKGROUND:25347226